JP2021530470A5 - - Google Patents
Info
- Publication number
- JP2021530470A5 JP2021530470A5 JP2021500105A JP2021500105A JP2021530470A5 JP 2021530470 A5 JP2021530470 A5 JP 2021530470A5 JP 2021500105 A JP2021500105 A JP 2021500105A JP 2021500105 A JP2021500105 A JP 2021500105A JP 2021530470 A5 JP2021530470 A5 JP 2021530470A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- compound
- cathepsin
- unsubstituted
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2018093886 | 2018-06-30 | ||
| CNPCT/CN2018/093886 | 2018-06-30 | ||
| PCT/CN2019/092488 WO2020001392A1 (en) | 2018-06-30 | 2019-06-24 | Cathepsin c inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021530470A JP2021530470A (ja) | 2021-11-11 |
| JP2021530470A5 true JP2021530470A5 (https=) | 2022-07-01 |
Family
ID=68986057
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021500105A Pending JP2021530470A (ja) | 2018-06-30 | 2019-06-24 | カテプシンｃ阻害剤 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20210114983A1 (https=) |
| EP (1) | EP3814324A4 (https=) |
| JP (1) | JP2021530470A (https=) |
| CN (1) | CN112601742A (https=) |
| WO (1) | WO2020001392A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020051424A1 (en) | 2018-09-07 | 2020-03-12 | Pic Therapeutics | Eif4e inhibitors and uses thereof |
| TW202146393A (zh) | 2020-03-03 | 2021-12-16 | 美商皮克醫療公司 | Eif4e抑制劑及其用途 |
| CN112920124B (zh) * | 2021-01-29 | 2024-03-01 | 安徽医科大学 | 一种嘧啶-2,4-二胺类化合物及其制备方法与应用 |
| CA3229560A1 (en) | 2021-08-25 | 2023-03-02 | Christopher L. Vandeusen | Eif4e inhibitors and uses thereof |
| US12157732B2 (en) | 2021-08-25 | 2024-12-03 | PIC Therapeutics, Inc. | eIF4E inhibitors and uses thereof |
| AU2023296161A1 (en) * | 2022-06-13 | 2025-01-02 | Alivexis, Inc. | Azacycloalkyl carbonyl cyclic amine compound |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9908884B2 (en) * | 2009-05-05 | 2018-03-06 | Dana-Farber Cancer Institute, Inc. | EGFR inhibitors and methods of treating disorders |
| WO2012112733A1 (en) * | 2011-02-16 | 2012-08-23 | Glaxosmithkline Llc | Cathepsin c inhibitors |
| CN103664878A (zh) * | 2012-09-12 | 2014-03-26 | 山东亨利医药科技有限责任公司 | 杂芳环及其衍生物类酪氨酸激酶抑制剂 |
| US9783504B2 (en) * | 2013-07-09 | 2017-10-10 | Dana-Farber Cancer Institute, Inc. | Kinase inhibitors for the treatment of disease |
| BR112016008632A8 (pt) * | 2013-10-21 | 2020-03-17 | Merck Patent Gmbh | compostos de heteroarila como inibidores de btk, seus usos, e composição farmacêutica |
| US10300058B2 (en) * | 2014-04-18 | 2019-05-28 | Xuanzhu Pharma Co., Ltd. | Tyrosine kinase inhibitor and uses thereof |
| CN114716390A (zh) * | 2015-04-07 | 2022-07-08 | Ela制药有限公司 | 用于治疗和/或预防细胞或组织坏死的组合物和方法 |
| WO2017097113A1 (zh) * | 2015-12-10 | 2017-06-15 | 深圳市塔吉瑞生物医药有限公司 | 用于抑制蛋白酪氨酸激酶活性的氨基嘧啶类化合物 |
-
2019
- 2019-06-24 EP EP19826742.9A patent/EP3814324A4/en not_active Withdrawn
- 2019-06-24 CN CN201980055883.7A patent/CN112601742A/zh active Pending
- 2019-06-24 WO PCT/CN2019/092488 patent/WO2020001392A1/en not_active Ceased
- 2019-06-24 JP JP2021500105A patent/JP2021530470A/ja active Pending
-
2020
- 2020-12-30 US US17/137,458 patent/US20210114983A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021530470A5 (https=) | ||
| JP2023516073A5 (https=) | ||
| JP2016518437A5 (https=) | ||
| HUP0303637A2 (hu) | Nitrogéntartalmú spirotriciklusos-származékok, eljárás előállításukra, valamint ezeket tartalmazó foszfodiészteráz-7-inhibitorként alkalmazható gyógyszerkészítmények | |
| AU2014267235A1 (en) | Sulphamoylthiophenamide derivatives and the use thereof as medicaments for the treatment of hepatitis B | |
| CN114555588A (zh) | 作为axl抑制剂的喹唑啉类化合物 | |
| MX2011009822A (es) | Derivados de tienopirimidinadiona como moduladores del trpa1. | |
| JP2021514400A5 (https=) | ||
| RU2016125306A (ru) | Новые пестицидные соединения и применения | |
| JP2013516393A5 (https=) | ||
| MX2011009821A (es) | Derivados de isotiazolo pirimidinadiona como moduladores del trpa1. | |
| JP2017524668A5 (https=) | ||
| EA022420B1 (ru) | Гетероциклические ингибиторы глутаминилциклазы (qc, ec 2.3.2.5) | |
| JP2010504346A5 (https=) | ||
| JP2014526500A5 (https=) | ||
| ME01294B (me) | Nova jedinjenja i kompozicije i metode upotrebe | |
| JP2008516986A5 (https=) | ||
| JP2018536678A5 (https=) | ||
| JP2018511647A5 (https=) | ||
| JP2013532652A5 (https=) | ||
| JP2014532626A5 (https=) | ||
| EP2483242A1 (en) | New histone deacetylase inhibitors based simultaneously on trisubstituted 1h-pyrroles and aromatic and heteroaromatic spacers | |
| MX2013008718A (es) | Inhibicion de il17 e ifn-gamma para tratamiento de inflamacion autoinmune. | |
| JP2013517279A5 (https=) | ||
| JP2021535213A5 (https=) |